BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 27023689)

  • 1. Opioid Treatment Patterns Following Prescription of Immediate-Release Hydrocodone.
    Ben-Joseph R; Bell JA; Brixner D; Kansal A; Paramore C; Chitnis A; Holly P; S Burgoyne D
    J Manag Care Spec Pharm; 2016 Apr; 22(4):358-66. PubMed ID: 27023689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing downstream healthcare resource utilization and costs based on prior utilization patterns of immediate-release hydrocodone.
    Ben-Joseph R; Bell JA; Chitnis A; Kansal A; Holly P; Paramore C; Wild H
    J Med Econ; 2016; 19(2):169-80. PubMed ID: 26451633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of a Federal Controlled Substance Act Schedule Change on Hydrocodone Combination Products Claims in a Medicaid Population.
    Tran S; Lavitas P; Stevens K; Greenwood BC; Clements K; Alper CJ; Lenz K; Price M; Hydery T; Arnold JL; Takeshita M; Bacon R; Peristere JP; Jeffrey PL
    J Manag Care Spec Pharm; 2017 May; 23(5):532-539. PubMed ID: 28448772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective cohort study of long-term immediate-release hydrocodone/acetaminophen use and acetaminophen dosing above the Food and Drug Administration recommended maximum daily limit among commercially insured individuals in the United States (2008-2013).
    DeVeaugh-Geiss A; Kadakia A; Chilcoat H; Alexander L; Coplan P
    J Pain; 2015 Jun; 16(6):569-79.e1. PubMed ID: 25827064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid tolerance and clinically recognized opioid poisoning among patients prescribed extended-release long-acting opioids.
    Young JC; Lund JL; Dasgupta N; Jonsson Funk M
    Pharmacoepidemiol Drug Saf; 2019 Jan; 28(1):39-47. PubMed ID: 29888409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of Immediate-Release and Extended-Release Opioid Analgesic Use in the Management of Chronic Pain, 2003-2014.
    Hwang CS; Kang EM; Ding Y; Ocran-Appiah J; McAninch JK; Staffa JA; Kornegay CJ; Meyer TE
    JAMA Netw Open; 2018 Jun; 1(2):e180216. PubMed ID: 30646061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-acting and Long-acting Opioids Utilization among Women Diagnosed with Endometriosis in the United States: A Population-based Claims Study.
    As-Sanie S; Soliman AM; Evans K; Erpelding N; Lanier RK; Katz NP
    J Minim Invasive Gynecol; 2021 Feb; 28(2):297-306.e2. PubMed ID: 32531340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment Patterns and Medication Use in Patients with Postherpetic Neuralgia.
    Gudin J; Fudin J; Wang E; Haylon T; Patel K; Goss TF
    J Manag Care Spec Pharm; 2019 Dec; 25(12):1387-1396. PubMed ID: 31589557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of prescription opioids with abuse-deterrent technology to address opioid abuse.
    Michna E; Kirson NY; Shei A; Birnbaum HG; Ben-Joseph R
    Curr Med Res Opin; 2014 Aug; 30(8):1589-98. PubMed ID: 24738694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of daily average consumption (DACON) of oxycodone and oxymorphone long-acting oral tablets.
    Rubino M; Summers KH; Puenpatom A; Fu C; Ohsfeldt RL; Ben-Joseph RH
    J Manag Care Pharm; 2011 Jun; 17(5):367-76. PubMed ID: 21657806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid Prescribing Among Adults With Disabilities in the United States After the 2014 Federal Hydrocodone Rescheduling Regulation.
    Liaw V; Kuo YF; Raji MA; Baillargeon J
    Public Health Rep; 2020 Jan; 135(1):114-123. PubMed ID: 31835012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid tolerance and urine drug testing among initiates of extended-release or long-acting opioids in Food and Drug Administration's Sentinel System.
    Larochelle MR; Cocoros NM; Popovic J; Dee EC; Kornegay C; Ju J; Racoosin JA
    J Opioid Manag; 2017; 13(5):315-327. PubMed ID: 29199397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Buprenorphine transdermal system utilization.
    Wallace L; Kadakia A
    Postgrad Med; 2017 Jan; 129(1):81-86. PubMed ID: 27901359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health Care Burden Associated with Outpatient Opioid Use Following Inpatient or Outpatient Surgery.
    Brummett CM; England C; Evans-Shields J; Kong AM; Lew CR; Henriques C; Zimmerman NM; Pawasauskas J; Oderda G
    J Manag Care Spec Pharm; 2019 Sep; 25(9):973-983. PubMed ID: 31313621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matching study design to prescribing intention: The prevalent new-user design for studying abuse-deterrent formulations of opioids.
    DiPrete BL; Oh G; Moga DC; Dasgupta N; Slavova S; Slade E; Delcher C; Pence BW; Ranapurwala SI
    Pharmacoepidemiol Drug Saf; 2024 May; 33(5):e5805. PubMed ID: 38720402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Hydrocodone Schedule Change With Opioid Prescriptions Following Surgery.
    Habbouche J; Lee J; Steiger R; Dupree JM; Khalsa C; Englesbe M; Brummett C; Waljee J
    JAMA Surg; 2018 Dec; 153(12):1111-1119. PubMed ID: 30140896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-acting opioid prescribing patterns of ophthalmic plastic surgeons in the medicare Part D database.
    Dryden SC; Rho JE; Nix GC; Vacheron AB; Reggie SN; Meador AG; Fleming JC; Wilson MW; Fowler BT
    Orbit; 2022 Oct; 41(5):585-590. PubMed ID: 34514944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment Patterns and Associated Health Care Costs Before and After Treatment Initiation Among Pulmonary Arterial Hypertension Patients in the United States.
    Burger CD; Ozbay AB; Lazarus HM; Riehle E; Montejano LB; Lenhart G; White RJ
    J Manag Care Spec Pharm; 2018 Aug; 24(8):834-842. PubMed ID: 29436260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human abuse potential of immediate-release/extended-release versus immediate-release hydrocodone bitartrate/acetaminophen: a randomized controlled trial in recreational users of prescription opioids.
    Devarakonda K; Kostenbader K; Zheng Y; Montgomery JB; Barrett T; Young JL; Webster LR
    Postgrad Med; 2015 Jan; 127(1):13-21. PubMed ID: 25584931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.